{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T21:30:44Z","timestamp":1782250244641,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02787-x","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:56:18Z","timestamp":1750481778000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["GDF-15 upregulates the SLC7A11\/GPX4 signaling axis and promotes mitoxantrone resistance in AML cells"],"prefix":"10.1186","volume":"30","author":[{"given":"Qian-wei","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,21]]},"reference":[{"key":"2787_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11912-020-0885-0","volume":"22","author":"E Ladikou","year":"2020","unstructured":"Ladikou E, Sivaloganathan H, Pepper A, Chevassut T. Acute myeloid leukaemia in its niche: the bone marrow microenvironment in acute myeloid leukaemia. Curr Oncol Rep. 2020;22:1\u20139.","journal-title":"Curr Oncol Rep"},{"issue":"2","key":"2787_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2174\/1574892813666171206123114","volume":"13","author":"AS Tikhomirov","year":"2018","unstructured":"Tikhomirov AS, Shtil AA, Shchekotikhin AE. Advances in the discovery of anthraquinone-based anticancer agents. Recent Pat Anti-Cancer Drug Discovery. 2018;13(2):159\u201383.","journal-title":"Recent Pat Anti-Cancer Drug Discovery"},{"issue":"1","key":"2787_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.canlet.2015.10.010","volume":"370","author":"Z Chen","year":"2016","unstructured":"Chen Z, Shi T, Zhang L, Zhu P, Deng M, Huang C, Hu T, Jiang L, Li J. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade. Cancer Lett. 2016;370(1):153\u201364.","journal-title":"Cancer Lett"},{"key":"2787_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2020.100712","volume":"52","author":"N Shahar","year":"2020","unstructured":"Shahar N, Larisch S. Inhibiting the inhibitors: targeting anti-apoptotic proteins in cancer and therapy resistance. Drug Resist Updates. 2020;52: 100712.","journal-title":"Drug Resist Updates"},{"issue":"21","key":"2787_CR5","doi-asserted-by":"publisher","first-page":"5134","DOI":"10.3390\/molecules29215134","volume":"29","author":"M Lee","year":"2024","unstructured":"Lee M, Kim H-G. Anti-cancer strategy based on changes in the role of autophagy depending on the survival environment and tumorigenesis stages. Molecules. 2024;29(21):5134.","journal-title":"Molecules"},{"issue":"1\u20132","key":"2787_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.drup.2012.02.001","volume":"15","author":"BC Shaffer","year":"2012","unstructured":"Shaffer BC, Gillet J-P, Patel C, Baer MR, Bates SE, Gottesman MM. Drug resistance: still a daunting challenge to the successful treatment of AML. Drug Resist Updates. 2012;15(1\u20132):62\u20139.","journal-title":"Drug Resist Updates"},{"issue":"12","key":"2787_CR7","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.humimm.2021.06.007","volume":"82","author":"RS Lodi","year":"2021","unstructured":"Lodi RS, Yu B, Xia L, Liu F. Roles and regulation of growth differentiation factor-15 in the Immune and tumor microenvironment. Hum Immunol. 2021;82(12):937\u201344.","journal-title":"Hum Immunol"},{"issue":"6","key":"2787_CR8","doi-asserted-by":"publisher","first-page":"654","DOI":"10.2174\/1381612825666190402101143","volume":"25","author":"L Fang","year":"2019","unstructured":"Fang L, Li F, Gu C. GDF-15: a multifunctional modulator and potential therapeutic target in cancer. Curr Pharm Des. 2019;25(6):654\u201362.","journal-title":"Curr Pharm Des"},{"key":"2787_CR9","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3389\/fimmu.2020.00951","volume":"11","author":"J Wischhusen","year":"2020","unstructured":"Wischhusen J, Melero I, Fridman WH. Growth\/differentiation factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint. Front Immunol. 2020;11:951.","journal-title":"Front Immunol"},{"key":"2787_CR10","doi-asserted-by":"publisher","first-page":"e14290","DOI":"10.1111\/eci.14290","volume":"1","author":"Y Xue","year":"2024","unstructured":"Xue Y, Zhang Y, Su Y, Zhao J, Yu D, Jo Y, Joo J, Lee HJ, Ryu D, Wei S. The implicated role of GDF15 in gastrointestinal cancer. Eur J Clin Invest. 2024;1:e14290.","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"2787_CR11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.14715\/cmb\/2024.70.3.24","volume":"70","author":"M Yang","year":"2024","unstructured":"Yang M, Guo M, Su C, Hao W, Xu Z. Knockdown of growth differentiation factor-15 restrains prostate cancer through regulating MAPK\/ERK signaling pathway. Cell Mol Biol (Noisy-le-grand). 2024;70(3):162\u20137.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"2787_CR12","doi-asserted-by":"crossref","unstructured":"Sher, G.; Masoodi, T.; Patil, K.; Akhtar, S.; Kuttikrishnan, S.; Ahmad, A.; Uddin, S. In Dysregulated FOXM1 signaling in the regulation of cancer stem cells, Seminars in cancer biology, 2022; Elsevier: pp 107\u2013121.","DOI":"10.1016\/j.semcancer.2022.07.009"},{"issue":"15","key":"2787_CR13","doi-asserted-by":"publisher","first-page":"12222","DOI":"10.3390\/ijms241512222","volume":"24","author":"N Bou Antoun","year":"2023","unstructured":"Bou Antoun N, Chioni A-M. Dysregulated signalling pathways driving anticancer drug resistance. Int J Mol Sci. 2023;24(15):12222.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2787_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41698-022-00272-w","volume":"6","author":"R Ge","year":"2022","unstructured":"Ge R, Wang Z, Cheng L. Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance. NPJ Prec Oncol. 2022;6(1):31.","journal-title":"NPJ Prec Oncol"},{"key":"2787_CR15","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00262-016-1820-y","volume":"65","author":"J Zong","year":"2016","unstructured":"Zong J, Keskinov AA, Shurin GV, Shurin MR. Tumor-derived factors modulating dendritic cell function. Cancer Immunol Immunother. 2016;65:821\u201333.","journal-title":"Cancer Immunol Immunother"},{"key":"2787_CR16","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s11255-016-1278-z","volume":"48","author":"E Lukaszyk","year":"2016","unstructured":"Lukaszyk E, Lukaszyk M, Koc-Zorawska E, Bodzenta-Lukaszyk A, Malyszko J. GDF-15, iron, and inflammation in early chronic kidney disease among elderly patients. Int Urol Nephrol. 2016;48:839\u201344.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"2787_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13052-023-01505-9","volume":"49","author":"NM Farag","year":"2023","unstructured":"Farag NM, Mousa M, Elsayed E, Ismeil A. GDF-15 and hepcidin as a therapeutic target for anemia in chronic kidney disease. Ital J Pediatr. 2023;49(1):106.","journal-title":"Ital J Pediatr"},{"key":"2787_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cca.2013.10.015","volume":"428","author":"F Jiang","year":"2014","unstructured":"Jiang F, Yu W-J, Wang X-H, Tang Y-T, Guo L, Jiao X-Y. Regulation of hepcidin through GDF-15 in cancer-related anemia. Clin Chim Acta. 2014;428:14\u20139.","journal-title":"Clin Chim Acta"},{"issue":"11","key":"2787_CR19","doi-asserted-by":"publisher","first-page":"5956","DOI":"10.3390\/ijms25115956","volume":"25","author":"S Lasaad","year":"2024","unstructured":"Lasaad S, Crambert G. GDF15, an Emerging Player in Renal Physiology and Pathophysiology. Int J Mol Sci. 2024;25(11):5956.","journal-title":"Int J Mol Sci"},{"key":"2787_CR20","unstructured":"Farra, N. L., Multiple Modes of Hepcidin Regulation in Breast Cancer. University of Connecticut: 2017."},{"key":"2787_CR21","doi-asserted-by":"publisher","first-page":"400","DOI":"10.2165\/00003495-199141030-00007","volume":"41","author":"D Faulds","year":"1991","unstructured":"Faulds D, Balfour JA, Chrisp P, Langtry HD. Mitoxantrone: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer. Drugs. 1991;41:400\u201349.","journal-title":"Drugs"},{"key":"2787_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2165\/00002512-199609020-00007","volume":"9","author":"CJ Dunn","year":"1996","unstructured":"Dunn CJ, Goa KL. Mitoxantrone: a review of its pharmacological properties and use in acute nonlymphoblastic leukaemia. Drugs Aging. 1996;9:122\u201347.","journal-title":"Drugs Aging"},{"key":"2787_CR23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00282-997-0163-8","volume":"39","author":"X Thomas","year":"1997","unstructured":"Thomas X, Archimbaud E. Mitoxantrone in the treatment of acute myelogenous leukemia: a review. Hematol Cell Ther. 1997;39:163\u201374.","journal-title":"Hematol Cell Ther"},{"key":"2787_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155288","volume":"124","author":"Z Chen","year":"2024","unstructured":"Chen Z, Zhu Q, Qi X, Yang L-R, Rong Y-X, Wei Q, Wu S-Q, Lu Q-W, Li L, Jiang M-D. Dual role of Nrf2\/HO-1 pathway in Z-ligustilide-induced ferroptosis against AML cells. Phytomedicine. 2024;124: 155288.","journal-title":"Phytomedicine"},{"issue":"1","key":"2787_CR25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41420-023-01483-1","volume":"9","author":"J Zhao","year":"2023","unstructured":"Zhao J, Zhang N, Ma X, Li M, Feng H. The dual role of ferroptosis in anthracycline-based chemotherapy includes reducing resistance and increasing toxicity. Cell Death Disc. 2023;9(1):184.","journal-title":"Cell Death Disc"},{"key":"2787_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.896792","volume":"9","author":"G Zhang","year":"2022","unstructured":"Zhang G, Yuan C, Su X, Zhang J, Gokulnath P, Vulugundam G, Li G, Yang X, An N, Liu C. Relevance of ferroptosis to cardiotoxicity caused by anthracyclines: mechanisms to target treatments. Front Cardiovasc Med. 2022;9: 896792.","journal-title":"Front Cardiovasc Med"},{"key":"2787_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117312","volume":"179","author":"H Li","year":"2024","unstructured":"Li H, Wang M, Huang Y. Anthracycline-induced cardiotoxicity: an overview from cellular structural perspective. Biomed Pharmacother. 2024;179: 117312.","journal-title":"Biomed Pharmacother"},{"key":"2787_CR28","first-page":"123297","volume":"1","author":"Z-G Chen","year":"2024","unstructured":"Chen Z-G, Xie Y-T, Yang C, Xiao T, Chen S-Y, Wu J-H, Guo Q-N, Gao L. M2 macrophages secrete GDF-15 to regulate iron metabolism and promote daunorubicin resistance in AML cells. Life Sci. 2024;1:123297.","journal-title":"Life Sci"},{"issue":"1","key":"2787_CR29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S1734-1140(09)70018-0","volume":"61","author":"T \u0160im\u016fnek","year":"2009","unstructured":"\u0160im\u016fnek T, \u0160t\u011brba M, Popelov\u00e1 O, Adamcov\u00e1 M, Hrdina R, Ger\u0161l V. Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacol Rep. 2009;61(1):154\u201371.","journal-title":"Pharmacol Rep"},{"key":"2787_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fphar.2014.00025","volume":"5","author":"E Gammella","year":"2014","unstructured":"Gammella E, Maccarinelli F, Buratti P, Recalcati S, Cairo G. The role of iron in anthracycline cardiotoxicity. Front Pharmacol. 2014;5:25.","journal-title":"Front Pharmacol"},{"key":"2787_CR31","unstructured":"Lettlov\u00e1, S., Mechanisms of resistance and iron metabolism in cancer stem cells. 2019."},{"key":"2787_CR32","doi-asserted-by":"crossref","unstructured":"Capel\u00f4a, T.; Benyahia, Z.; Zampieri, L. X.; Blackman, M. C.; Sonveaux, P. In Metabolic and non-metabolic pathways that control cancer resistance to anthracyclines, Seminars in cell & developmental biology, 2020; Elsevier: pp 181\u2013191.","DOI":"10.1016\/j.semcdb.2019.05.006"},{"issue":"5","key":"2787_CR33","first-page":"685","volume":"68","author":"S Hori","year":"1977","unstructured":"Hori S, Shirai M, Hirano S, Oki T, Inui T, Tsukagoshi S, Ishizuka M, Takeuchi T, Umezawa H. Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity. GANN Jap J Cancer Res. 1977;68(5):685\u201390.","journal-title":"GANN Jap J Cancer Res"},{"issue":"11","key":"2787_CR34","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1166\/jbn.2015.2145","volume":"11","author":"MD Glasgow","year":"2015","unstructured":"Glasgow MD, Chougule MB. Recent developments in active tumor targeted multifunctional nanoparticles for combination chemotherapy in cancer treatment and imaging. J Biomed Nanotechnol. 2015;11(11):1859\u201398.","journal-title":"J Biomed Nanotechnol"},{"issue":"39","key":"2787_CR35","doi-asserted-by":"publisher","first-page":"8203","DOI":"10.2174\/0929867328666210720143721","volume":"28","author":"S Dallavalasa","year":"2021","unstructured":"Dallavalasa S, Beeraka NM, Basavaraju CG, Tulimilli SV, Sadhu SP, Rajesh K, Aliev G, Madhunapantula SV. The role of tumor associated macrophages (TAMs) in cancer progression, chemoresistance, angiogenesis and metastasis-current status. Curr Med Chem. 2021;28(39):8203\u201336.","journal-title":"Curr Med Chem"},{"issue":"12","key":"2787_CR36","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.2174\/1568026623666230201145909","volume":"23","author":"HA Lafta","year":"2023","unstructured":"Lafta HA, AbdulHussein AH, Al-Shalah SA, Alnassar YS, Mohammed NM, Akram SM, Qasim MT, Najafi M. Tumor-associated macrophages (TAMs) in cancer resistance; modulation by natural products. Curr Top Med Chem. 2023;23(12):1104\u201322.","journal-title":"Curr Top Med Chem"},{"issue":"4","key":"2787_CR37","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/cbin.11528","volume":"45","author":"D Tu","year":"2021","unstructured":"Tu D, Dou J, Wang M, Zhuang H, Zhang X. M2 macrophages contribute to cell proliferation and migration of breast cancer. Cell Biol Int. 2021;45(4):831\u20138.","journal-title":"Cell Biol Int"},{"issue":"1","key":"2787_CR38","first-page":"948098","volume":"2012","author":"N-B Hao","year":"2012","unstructured":"Hao N-B, L\u00fc M-H, Fan Y-H, Cao Y-L, Zhang Z-R, Yang S-M. Macrophages in tumor microenvironments and the progression of tumors. J Immunol Res. 2012;2012(1):948098.","journal-title":"J Immunol Res"},{"issue":"1","key":"2787_CR39","doi-asserted-by":"publisher","first-page":"e0279752","DOI":"10.1371\/journal.pone.0279752","volume":"18","author":"B Yan","year":"2023","unstructured":"Yan B, Shi R, Lu Y-Y, Fang D-D, Ye M-N, Zhou Q-M. Shenqi Fuzheng injection reverses M2 macrophage-mediated cisplatin resistance through the PI3K pathway in breast cancer. PLoS ONE. 2023;18(1):e0279752.","journal-title":"PLoS ONE"},{"key":"2787_CR40","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1007\/s10120-015-0579-8","volume":"19","author":"T Yamaguchi","year":"2016","unstructured":"Yamaguchi T, Fushida S, Yamamoto Y, Tsukada T, Kinoshita J, Oyama K, Miyashita T, Tajima H, Ninomiya I, Munesue S. Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination. Gastric Cancer. 2016;19:1052\u201365.","journal-title":"Gastric Cancer"},{"issue":"26","key":"2787_CR41","doi-asserted-by":"publisher","first-page":"5158","DOI":"10.1038\/s41388-019-0782-x","volume":"38","author":"JE Park","year":"2019","unstructured":"Park JE, Dutta B, Tse SW, Gupta N, Tan CF, Low JK, Yeoh KW, Kon OL, Tam JP, Sze SK. Hypoxia-induced tumor exosomes promote M2-like macrophage polarization of infiltrating myeloid cells and microRNA-mediated metabolic shift. Oncogene. 2019;38(26):5158\u201373.","journal-title":"Oncogene"},{"issue":"1","key":"2787_CR42","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/imr.12603","volume":"280","author":"S Saha","year":"2017","unstructured":"Saha S, Shalova IN, Biswas SK. Metabolic regulation of macrophage phenotype and function. Immunol Rev. 2017;280(1):102\u201311.","journal-title":"Immunol Rev"},{"issue":"3","key":"2787_CR43","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s12020-023-03377-9","volume":"81","author":"P Iglesias","year":"2023","unstructured":"Iglesias P, Silvestre RA, D\u00edez JJ. Growth differentiation factor 15 (GDF-15) in endocrinology. Endocrine. 2023;81(3):419\u201331.","journal-title":"Endocrine"},{"key":"2787_CR44","doi-asserted-by":"publisher","first-page":"1264530","DOI":"10.3389\/fendo.2023.1264530","volume":"14","author":"J Jena","year":"2023","unstructured":"Jena J, Garc\u00eda-Pe\u00f1a LM, Pereira RO. The roles of FGF21 and GDF15 in mediating the mitochondrial integrated stress response. Front Endocrinol. 2023;14:1264530.","journal-title":"Front Endocrinol"},{"issue":"3","key":"2787_CR45","doi-asserted-by":"publisher","first-page":"e48804","DOI":"10.15252\/embr.201948804","volume":"21","author":"M Ost","year":"2020","unstructured":"Ost M, Igual Gil C, Coleman V, Keipert S, Efstathiou S, Vidic V, Weyers M, Klaus S. Muscle-derived GDF15 drives diurnal anorexia and systemic metabolic remodeling during mitochondrial stress. EMBO Rep. 2020;21(3):e48804.","journal-title":"EMBO Rep"},{"key":"2787_CR46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/ggi.12724","volume":"16","author":"Y Fujita","year":"2016","unstructured":"Fujita Y, Taniguchi Y, Shinkai S, Tanaka M, Ito M. Secreted growth differentiation factor 15 as a potential biomarker for mitochondrial dysfunctions in aging and age-related disorders. Geriatr Gerontol Int. 2016;16:17\u201329.","journal-title":"Geriatr Gerontol Int"},{"key":"2787_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.615461","volume":"8","author":"J Prasuhn","year":"2021","unstructured":"Prasuhn J, Davis RL, Kumar KR. Targeting mitochondrial impairment in Parkinson\u2019s disease: challenges and opportunities. Front Cell Dev Biol. 2021;8: 615461.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"2787_CR48","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.18632\/oncotarget.13649","volume":"8","author":"Y-L Li","year":"2016","unstructured":"Li Y-L, Chang JT, Lee L-Y, Fan K-H, Lu Y-C, Li Y-C, Chiang C-H, You G-R, Chen H-Y, Cheng A-J. GDF15 contributes to radioresistance and cancer stemness of head and neck cancer by regulating cellular reactive oxygen species via a SMAD-associated signaling pathway. Oncotarget. 2016;8(1):1508.","journal-title":"Oncotarget"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02787-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02787-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02787-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T17:02:29Z","timestamp":1750525349000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02787-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,21]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2787"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02787-x","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,21]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This animal study was reviewed and approved by the Experimental Animal Welfare and Ethics Committee of the Third Military Medical University on March 5, 2021 (SYXK (Ethics) 20,170,002). Primary AML cells were obtained from the bone marrow blood samples of leukemia patients with informed consent. The study protocol was approved by the Ethics Committee of Shanghai Xinchao Biotechnology Co., Ltd. and complies with the Declaration of Helsinki (Permit No.: SHXC2021YF02).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"504"}}